Omada Health, Inc. (NASDAQ:OMDA) Receives $24.57 Average PT from Brokerages

Key Points

• Omada Health, Inc. has received a consensus "Buy" rating from seven analysts, with an average 12-month target price of $24.57.
• Despite missing earnings estimates with a report of ($0.22) EPS, the company achieved revenue of $61.37 million for the quarter, exceeding expectations.
• Institutional investors have shown significant interest, with recent purchases totaling over $44 million from Perceptive Advisors LLC alone in the second quarter.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) has been given a consensus recommendation of "Buy" by the seven analysts that are currently covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have covered the stock in the last year is $24.5714.

OMDA has been the subject of several research analyst reports. Wall Street Zen raised Omada Health to a "hold" rating in a research note on Monday, June 16th. JPMorgan Chase & Co. assumed coverage on Omada Health in a report on Tuesday, July 1st. They set an "overweight" rating and a $19.00 price objective on the stock. Morgan Stanley started coverage on Omada Health in a research note on Tuesday, July 1st. They issued an "overweight" rating and a $25.00 target price for the company. Canaccord Genuity Group increased their price target on shares of Omada Health from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Finally, Barclays boosted their price objective on shares of Omada Health from $21.00 to $24.00 and gave the stock an "overweight" rating in a report on Friday, August 8th.

Institutional Trading of Omada Health

Institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new position in shares of Omada Health during the second quarter valued at about $32,000. Ilex Capital Partners UK LLP purchased a new stake in Omada Health during the 2nd quarter valued at about $201,000. Sandia Investment Management LP bought a new position in Omada Health during the 2nd quarter worth approximately $366,000. XTX Topco Ltd purchased a new position in Omada Health in the 2nd quarter worth approximately $414,000. Finally, Walleye Capital LLC purchased a new position in Omada Health in the 2nd quarter worth approximately $458,000.

Omada Health Price Performance

Shares of OMDA traded down $0.14 during mid-day trading on Wednesday, reaching $21.32. 379,922 shares of the stock traded hands, compared to its average volume of 439,192. The business has a fifty day simple moving average of $18.25. Omada Health has a 1 year low of $14.14 and a 1 year high of $28.40.

Omada Health (NASDAQ:OMDA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.07). The firm had revenue of $61.37 million for the quarter, compared to analysts' expectations of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.